Free Trial

Scancell (LON:SCLP) Stock Price Down 8.9% - What's Next?

Scancell logo with Medical background

Scancell Holdings plc (LON:SCLP - Get Free Report) shares fell 8.9% during trading on Monday . The stock traded as low as GBX 7.72 ($0.10) and last traded at GBX 7.72 ($0.10). 395,448 shares were traded during trading, a decline of 51% from the average session volume of 801,264 shares. The stock had previously closed at GBX 8.47 ($0.11).

Scancell Price Performance

The business has a 50-day simple moving average of GBX 8.80 and a 200 day simple moving average of GBX 11.60. The company has a current ratio of 3.42, a quick ratio of 13.01 and a debt-to-equity ratio of -566.79. The stock has a market cap of £82.86 million, a P/E ratio of -12.27 and a beta of 0.35.

Scancell (LON:SCLP - Get Free Report) last released its quarterly earnings results on Thursday, January 30th. The company reported GBX (1.35) (($0.02)) earnings per share (EPS) for the quarter. On average, analysts forecast that Scancell Holdings plc will post -2.5361112 earnings per share for the current year.

About Scancell

(Get Free Report)

Scancell LSE: SCLP is a clinical stage immunotherapy biotech company developing treatments for significant unmet needs in cancer. We aim to translate our innovation and creativity into increased and durable responses in patients without compromising safety, addressing hard-to-treat cancers. Scancell has developed a pipeline of ‘off-the-shelf' vaccines to induce immune responses and highly tumour specific monoclonal antibodies to redirect immune cells or drugs.

See Also

Should You Invest $1,000 in Scancell Right Now?

Before you consider Scancell, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Scancell wasn't on the list.

While Scancell currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Buy the Fear: 3 Down Stocks That Could 10x Your Profits
Congress Bought THESE Stocks as Tariffs Tanked the Market
5 Stocks to BUY Now as Tariff Uncertainty Fades

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines